Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Zongertinib
Trade Name
Synonyms BI-1810631|BI1810631|BI 1810631
Drug Descriptions

Zongertinib is an ERBB2 (HER2) selective inhibitor with potential anti-tumor activity (J of Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS9143, PMID: 36528522).

DrugClasses HER2 Inhibitor 42
CAS Registry Number 2728667-27-2
NCIT ID C189906

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Adagrasib + Zongertinib Adagrasib Zongertinib 0 0
Ado-trastuzumab emtansine + Zongertinib Ado-trastuzumab emtansine Zongertinib 0 1
Trastuzumab deruxtecan + Zongertinib Trastuzumab deruxtecan Zongertinib 0 1
Zongertinib Zongertinib 0 3


Additional content available in CKB BOOST